Latest News for our Portfolio Companies

Koya Medical News Page

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…

Casey FrushourFebruary 3, 2022

Fifth Eye News Page Press Release

Fifth Eye Receives FDA Clearance to Market AHI System™

Fifth Eye™, a provider of intuitive real-time clinical analytics, today announced the FDA provided clearance…

Casey FrushourJanuary 31, 2022

EQRx News Page

EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results

EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering…

Casey FrushourJanuary 18, 2022

EQRx News Page

EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…

Casey FrushourJanuary 10, 2022

EQRx Home Page News Page

EQRx Debuts as Publicly Traded Company

CM Life Sciences III (Nasdaq: CMLT, CMLTW, CMLTU), a life science-focused special purpose acquisition company,…

Arboretum_JDDecember 17, 2021

Avation Medical News Page

Avation Medical Announces the Appointment of Industry Veterans to Board of Directors

Avation Medical, an innovative advanced neuromodulation and digital health company pioneering closed-loop, wearable neuromodulation therapies…

Arboretum_JDDecember 9, 2021

Home Page News Page Pear Therapeutics

Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Company

Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription…

Arboretum_JDDecember 6, 2021

EQRx News Page

EQRx and CM Life Sciences III Announce Stockholder Meeting Details to Vote on Proposed Business Combination

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…

Arboretum_JDDecember 2, 2021

News Page Pear Therapeutics

Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics…

Arboretum_JDNovember 23, 2021

News

Success Begins Here

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies

Fifth Eye Receives FDA Clearance to Market AHI System™

EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results

EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines

EQRx Debuts as Publicly Traded Company

Avation Medical Announces the Appointment of Industry Veterans to Board of Directors

Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Company

EQRx and CM Life Sciences III Announce Stockholder Meeting Details to Vote on Proposed Business Combination

Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

News & Insights

ARCHIVES